Examining changes over time in CLL cell surface markers to identify cells at different stages
iwCLL – International Workshop on Chronic Lymphocytic Leukemia
Federico Caligaris-Cappio et al.
Venetoclax in combination with antibodies in the treatment of CLL
Preliminary results of a phase Ib study combining ABT-199 and obinutuzumab in CLL
B-cell and T-cell receptors: why it is important to understand their function